CXCR2 and cholangiocarcinoma: Recent studies have shown that CXCR2 can be used as a valuable independent prognostic marker in patients with cholangiocarcinoma, and its mediated immune response may have a tumor inhibition effect on cholangiocarcinoma cells [43].